Markets:

Overview

News

Currencies

International

Treasuries

Neuronetics, Inc. - Common Stock (NQ:STIM)

1.745 +0.225 (+14.80%)

Streaming Delayed Price Updated: 1:23 PM EDT, Apr 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Neuronetics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Neuronetics (STIM) Q4 2025 Earnings Transcript ↗

March 17, 2026

Neuronetics (STIM) Q4 2025 Earnings Transcript

Via The Motley Fool

NEURONETICS INC (NASDAQ:STIM) Reports Q4 Revenue Beat but Shares Drop on Cautious Outlook ↗

March 17, 2026

Via Chartmill

Which stocks are experiencing notable movement on Wednesday? ↗

February 11, 2026

Via Chartmill

Top stock movements in today's session. ↗

February 11, 2026

Via Chartmill

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

February 11, 2026

Via Chartmill

Get insights into the top gainers and losers of Wednesday's pre-market session. ↗

February 11, 2026

Via Chartmill

Wondering what's happening in today's after-hours session? ↗

February 10, 2026

Via Chartmill

Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November ↗

November 18, 2025

Via Benzinga

Tuesday's pre-market session: top gainers and losers ↗

November 04, 2025

The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

NEURONETICS INC (NASDAQ:STIM) Stock Plummets 22% on Q3 2025 Revenue Miss ↗

November 04, 2025

Neuronetics (STIM) Q3 2025 results: revenue miss sparks a 22% stock drop despite a narrower-than-expected EPS loss.

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 06, 2025

Via Benzinga

Neuronetics Inc (NASDAQ:STIM) Reports Mixed Q2 2025 Earnings: Revenue Beat Overshadowed by Wider-Than-Expected Loss ↗

August 05, 2025

Neuronetics (STIM) reported mixed Q2 2025 results, beating revenue estimates but posting a wider-than-expected loss, causing a 9% pre-market drop. Greenbrook clinics hit record revenue.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 27, 2025

Via Benzinga

Earnings Scheduled For March 4, 2025 ↗

March 04, 2025

Via Benzinga

What's going on in today's pre-market session ↗

February 07, 2025

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 07, 2025

Via Benzinga

These stocks are moving in today's after hours session ↗

February 06, 2025

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 12, 2024

Via Benzinga

Retractable Technologies And 2 Other Penny Stocks Executives Are Buying ↗

September 09, 2024

Via Benzinga

Butterfly Network And 3 Other Stocks Under $2 Executives Are Aggressively Buying ↗

September 03, 2024

Via Benzinga

Gold Gains Over 1%; Starbucks Shares Move Higher ↗

August 12, 2024

Via Benzinga

Noninvasive Treatment Provider Neuronetics Agrees To Merge With Canadian Firm Greenbrook TMS; Reports Q2 Earnings And Guidance Below Expectations ↗

August 12, 2024

Neuronetics to acquire Greenbrook TMS (OTC: GBNHF) in an all-stock deal, doubling revenue to $145M. The combined company expects mid-teens growth in 2025 and 2026, with $15M in cost savings and...

Via Benzinga

Crude Oil Surges 2%; B. Riley Financial Shares Plunge ↗

August 12, 2024

Via Benzinga

STIM Stock Earnings: Neuronetics Misses EPS, Misses Revenue for Q2 2024 ↗

August 12, 2024

STIM stock results show that Neuronetics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

Dow Dips 150 Points; Monday.com Posts Upbeat Earnings ↗

August 12, 2024

Via Benzinga

Topics Stocks

3 Neurotech Stocks Bridging Mind and Machine ↗

July 18, 2024

These neurotech stocks stand at the cutting edge of healthcare, but early entrants in new fields tend to be long-term winners.

Via InvestorPlace

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.